Haemonetics Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Welcome, everyone, to day 1 of the Morgan Stanley Healthcare Conference. I'm Drew Ranieri, one of the medical device analysts here. It's my pleasure to have Chris Simon, President and Chief Executive Officer of Haemonetics with us here today. And there's a significant amount to talk about.
But before we jump into it, just a quick disclaimer. But for important disclosures, please see the Morgan Stanley research disclosure website at morganstaley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales rep.
But Chris, thanks for being here today. I really appreciate it for -- and thank you for your time.
Questions & Answers
And I just want to start off this morning maybe on the Plasma business and kind of where recovery stands. So recovery in plasma collection continues to be kind of -- continues to lag, especially in your first quarter.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
